Provided by Tiger Fintech (Singapore) Pte. Ltd.

SIHUAN PHARM

0.660
+0.000
Volume:30.14M
Turnover:20.09M
Market Cap:6.11B
PE:-26.54
High:0.680
Open:0.670
Low:0.650
Close:0.660
Loading ...

Sihuan Pharmaceutical Unit's Diabetes Drug Gets Registration Approval in China

MT Newswires Live
·
24 Apr

BRIEF-Sihuan Pharma Says Dapagliflozin Tablets Obtained Drug Registration Approval From NMPA

Reuters
·
23 Apr

Sihuan Pharma - Dapagliflozin Tablets Developed by Huisheng Biopharmaceutical Obtained Drug Registration Approval From Nmpa

THOMSON REUTERS
·
23 Apr

BRIEF-Sihuan Pharma Repurchased 10 Mln Shares At Average Price Of HK$0.6274 Per Share

Reuters
·
16 Apr

Sihuan Pharma - Repurchased 10 Mln Shares at Average Price of HK$0.6274 per Share

THOMSON REUTERS
·
16 Apr

Sihuan Pharmaceutical Buys Back Shares

MT Newswires Live
·
10 Apr

BRIEF-Sihuan Pharma Intends To Exercise Its Powers Under General Mandate To Repurchase Shares Of Co

Reuters
·
09 Apr

Sihuan Pharma - Intends to Exercise Its Powers Under General Mandate to Repurchase Shares of Company

THOMSON REUTERS
·
09 Apr

Sihuan Pharma - Repurchased 10 Mln Shares of Co at Average Price of HK$0.5866 per Share

THOMSON REUTERS
·
09 Apr

BRIEF-Sihuan Pharma Repurchased A Total Of 15 Million Shares Of Co

Reuters
·
08 Apr

Sihuan Pharma - Repurchased a Total of 15 Mln Shares of Co at an Average Price of HK$0.5836 per Share

THOMSON REUTERS
·
07 Apr

Sihuan Pharmaceutical Unit Gets China Nod for Facial Filler

MT Newswires Live
·
03 Apr

BRIEF-Sihuan Pharma Obtains Approval For Injectable Polycaprolactone Microsphere Facial Filler

Reuters
·
02 Apr

Sihuan Pharma - Injectable Polycaprolactone Microsphere Facial Filler Obtained Registration Approval From Nmpa

THOMSON REUTERS
·
02 Apr

Sihuan Pharmaceutical Increases Investment in Medical Aesthetics Unit; Shares Rise 5%

MT Newswires Live
·
01 Apr

BRIEF-Sihuan Pharma Says Meiyan Space, Others To Increase Registered Capital Of Meifu Co

Reuters
·
01 Apr

Sihuan Pharma - Meiyan Space, Hainan Temmei, and Meifu Co to Increase Registered Capital of Meifu Co From RMB1 Mln to RMB50 Mln

THOMSON REUTERS
·
01 Apr

Sihuan Pharmaceutical Holdings Group Full Year 2024 Earnings: CN¥0.023 loss per share (vs CN¥0.006 loss in FY 2023)

Simply Wall St.
·
31 Mar

BRIEF-Sihuan Pharmaceutical Holdings Group FY Gross Profit RMB 1,241.7 Million

Reuters
·
28 Mar

Sihuan Pharmaceutical Holdings Group FY Gross Margin 65.3%

THOMSON REUTERS
·
28 Mar